Arranon and areflexia Patient Reports February 13, 2012

Arranon Side Effects Report #5537374-4
Arranon side effect was reported by a Physician from UNITED STATES on Nov 29, 2007. Male patient, child 12 years of age, weighting 132.3 lb, was diagnosed with t-cell chronic lymphocytic leukaemia and was treated with Arranon. After drug was administered, patient experienced the following side effects: abasia, areflexia, asthenia, burning sensation, dysarthria, eye disorder, facial paresis, faecal incontinence, guillain-barre syndrome . Arranon dosage: unknown. During the same period patient was treated with METHOTREXATE, SEPTRA. Patient was hospitalized and became disabled. Patient recovered.

Arranon Side Effects Report #5489645-8
Arranon side effect was reported by a Physician from UNITED STATES on Oct 12, 2007. Male patient, child 12 years of age, was treated with Arranon. After drug was administered, patient experienced the following side effects: abasia, areflexia, asthenia, burning sensation, dysarthria, facial paresis, hallucination, movement disorder , somnolence. Arranon dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.

Arranon Side Effects Report #5491975-0
Arranon side effect was reported by a Physician from UNITED STATES on Oct 19, 2007. Male patient, child 12 years of age, weighting 132.3 lb, was treated with Arranon. After drug was administered, patient experienced the following side effects: abasia, areflexia, asthenia, burning sensation, dysarthria, facial paresis, faecal incontinence, hallucination, movement disorder . Arranon dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.

Arranon Side Effects Report #5614150-5
Arranon side effect was reported by a Physician from UNITED STATES on Feb 01, 2008. Male patient, child 12 years of age, weighting 132.3 lb, was treated with Arranon. After drug was administered, patient experienced the following side effects: abasia, areflexia, aspiration, asthenia, burning sensation, dysarthria, dysphagia, eye disorder, facial paresis. Arranon dosage: unknown. During the same period patient was treated with METHOTREXATE, SEPTRA. Patient was hospitalized and became disabled. Patient recovered.